Spiacenti, l'offerta non è più disponibile,
ma puoi eseguire una nuova ricerca o esplorare offerte simili:

Pulimentatori Accessori Metallici Per La Moda

DESCRIZIONE Importante Azienda SpA ricerca e seleziona per azienda operante nel settore degli accessori moda 5 pulimentatori. Si richiede esperienza nella pu...


Italia

Pubblicato 23 days ago

Product Manager Leather Goods

Country: Italy Description: Four Corners, recruiter specializzato nella ricerca e selezione di professional e manager nei settori Fashion, Luxury e Lifestyle...


Adh Personal Thüringen - Italia

Pubblicato 22 days ago

Senior Visual & Ui Designer

Siamo una realtà digitale in continua espansione, che lavora per realizzare esperienze memorabili tramite l'utilizzo di tecnologie e metodologie dirompenti. ...


Crispy Bacon Srl - Italia

Pubblicato 22 days ago

Piping And Layout Designer

thyssenkrupp nucera Italy is the Italian branch located in Milano, specialized on design and supply of electrochemical plants for the production of green hyd...


Thyssenkrupp Presta Ag - Italia

Pubblicato 22 days ago

Director, Financial Planning & Analysis

Dettagli della offerta

Job Description - Director, Financial Planning & Analysis (230855) Job Number:
Director, Financial Planning & Analysis (230855)
Overview
The Director of R&D Finance is a key member of Alnylam's Finance Business Partner team, working with business leaders across the organization. This role will provide financial leadership to the company's external partnerships and collaborations and it will also provide support related to the forecasting of the company's Collaboration and Royalty Revenue.
Key Responsibilities
Provide finance leadership for the company's alliances on both recurring deliverables (budgets, forecasts, variance analysis, etc.) and ad hoc efforts working in close partnership with R&D expertise areas, program teams, Alliance Management and other internal and external stakeholders. Track potential strategic and operational financial risks related to the company's alliances, clearly and pro-actively surface these issues, and partner with the appropriate internal stakeholders to address problem areas. Manage the budgeting and forecasting for Collaboration and Royalty Revenue. Develop associated materials to be shared with key internal stakeholders including the CFO as well as the Board of Directors. Develop and maintain tools and processes that can support the group's current needs while also being able to scale for future growth. Collaborate with key stakeholders on opportunities to enhance or improve existing processes and reporting for Alliance Finance and Collaboration and Royalty Revenue, successfully implementing changes where appropriate. Develop strong relationships with key members of Global Finance organization and support special projects and ad hoc analyses as necessary. Qualifications
Bachelor's Degree in Finance or other degrees with quantitative focus (e.g. Statistics, Econometrics, Mathematics), business and business insights (e.g. MBA) preferred. Must have 8+ years work experience in a combination of FP&A, accounting, valuation and/or other strategic finance roles. Must have 4+ years of work experience in biotech / pharma industry, R&D experience required. Prior experience providing financial support to external partnerships and collaborations strongly preferred. Demonstrated ability to pivot between high-level strategic discussions and operationally executing on deliverables. Excellent interpersonal skills and ability to work effectively with multiple functions and with stakeholders of various levels of seniority. Proven ability to work with a high level of integrity, accuracy, and attention to detail. Maintain a positive, flexible, client-service attitude with business teams. About Alnylam
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.
#J-18808-Ljbffr


Salario Nominale: Da concordare

Risorsa: Grabsjobs_Co

Funzione Lavorativa:

Requisiti

Built at: 2025-01-06T02:24:01.867Z